Integrated Pharm Inc (INTP) 0.0009 $INTP Intec Pharma

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Integrated Pharm Inc (INTP) 0.0009 $INTP

Intec Pharma Appoints VP of Clinical and Regulatory Affairs
PR Newswire - Tue May 03, 7:00AM CDT
Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTP), a clinical-stage biopharmaceutical company, today announced the appointment of Pnina Strauss-Levy as Vice President, Clinical and Regulatory Affairs.
NTEC: 4.57 (-0.07)

Intec Pharma Enrolls First Patient in Pivotal Phase III Clinical Trial of AP-CDLD for Advanced Parkinson's Disease Patients
PR Newswire - Mon Apr 04, 6:00AM CDT
Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTP), a clinical-stage biopharmaceutical company, today announced the enrollment in the U.S. of the first patient in its pivotal Phase III clinical trial for its lead product candidate, the Accordion Pill Carbidopa/Levodopa, or AP-CDLD, for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients.
NTEC: 4.57 (-0.07)

Mr. Zvika Joseph to Step Down as Chairman of the Board of Directors
Marketwired - Thu Mar 17, 9:30AM CDT
Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTP), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, announced today that Mr. Zvika Joseph has resigned from his position as director and Chairman of the board of directors. As reason for this step Mr. Joseph stated personal reasons.
NTEC: 4.57 (-0.07)

Intec Pharma Ltd. Announces Availability of Its Annual Report on Form 20-F Through Its Website
Marketwired - Mon Mar 14, 6:30AM CDT
Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTP), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, announced today that its annual report on Form 20-F, containing audited financial statements for the year ended December 31, 2015, as filed with the Securities and Exchange Commission on March 14, 2016, is available through its website (http://intecpharma.com). Shareholders may receive a hard copy of the annual report free of charge upon request to the Company.
NTEC: 4.57 (-0.07)

Intec Pharma Completed a Phase I Clinical Trial With Its Third Pipeline Product
Marketwired - Thu Mar 10, 7:00AM CST
Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTP), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, today announced that it has completed a Phase I clinical trial with its third pipeline product.
NTEC: 4.57 (-0.07)

Intec Pharma to Present at Biotech Showcase 2016
Marketwired - Tue Jan 05, 6:00AM CST
Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTP), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, today announced that its Chief Executive Officer, Zeev Weiss, will present at Biotech Showcase on January 13, 2016 at 10:30 a.m. PT. The conference will be held in San Francisco, CA.
NTEC: 4.57 (-0.07)

Intec Pharma Further Expands Intellectual Property With a New Patent for the Accordion Pill Zaleplon in Europe
Marketwired - Wed Dec 16, 6:00AM CST
Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTP), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, today announced that the Company has been informed by the European Patent Office (EPO) that a European patent will be granted December 23, 2015 on the Company's European Patent Application for a "Zaleplon gastroretentive drug delivery system."
NTEC: 4.57 (-0.07)

Intec Pharma Receives an IRB Approval to Initiate Phase III Clinical Trial of AP - CDLD for the Treatment of Parkinson's Disease
Marketwired - Mon Dec 14, 7:10AM CST
Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTP), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, today announced that it has received a US centralized institutional review board (IRB) approval to initiate its Phase III clinical trial for its lead product, the Accordion Pill Carbidopa/Levodopa, or AP-CDLD, for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients.
NTEC: 4.57 (-0.07)

Intec Pharma Enters Phase I Clinical Trial With Its Third Pipeline Product
Marketwired - Tue Dec 08, 7:30AM CST
Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTP), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, today announced that it is entering a Phase I clinical trial with its third pipeline product.
NTEC: 4.57 (-0.07)

Intec Pharma Reports Results for the Third Quarter of 2015
Marketwired - Thu Nov 05, 3:30PM CST
Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTP) ("Intec Pharma" or the "Company" , an Israeli clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, today announced its financial results for the third quarter ended September 30, 2015 and provided a business update. Results are presented in New Israel Shekels (NIS) with a convenience translation to US$ provided using the Bank of Israel exchange rate of NIS 3.923 to $1.00 at September 30, 2015.
NTEC: 4.57 (-0.07)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tchah Sup Kim: A Retrospective at KCCNY in 2026

Updated Category News Views 3

A Glimpse into Tchah Sup Kim's Legacy Stumble into the world of Tchah Sup Kim (1940–2022) this fall at the Korean Cultural Center New York. Kim's posthumous retrospective, "The Key to a New World," brings together over 130 of his works alongside archival materials, offering a comprehensive dive into a mind that spent decades between New York and Korea. The exhibit,...

Continue Reading
Zoomlion Boosts Mining Gear Amid Global Revenue Surge

Updated Category News Views 4

An Ambitious Expansion Overhaul Alright, let's talk Zoomlion Heavy Industry Science & Technology Co., Ltd. They're not just making a splash; they're wading knee-deep into expanding their mining machinery operations and taking charge in international markets. You see, in the first half of 2026, this Chinese behemoth saw its mining machinery business skyrocket by over...

Continue Reading
Retail Trading Platforms Report Record Growth in 2026

Updated Category News Views 3

A Boom in Self-Directed Investing Times are changing, folks. More people than ever are taking finance into their own hands, wielding smartphones like fiscal swords in the name of self-directed investment. No middlemen, no fancy office, just straight-up trading from wherever you might be perched. Four major platforms now boast over 41 million funded accounts combined, each...

Continue Reading
Kexing Biopharm Expands Global Reach at CPHI Milan

Updated Category News Views 8

Kexing Biopharm's Showstopper Moment in Milan Call it a strategic blowout or just audacious timing—Kexing Biopharm's move at the CPHI Milan 2026 has painted a clear picture. From October 6th to 8th, Milan was the stage where Kexing rolled out its showcase, bragging about a pipeline that screams innovation and possibility. And let’s be honest, their timing couldn’t...

Continue Reading
Jiangxi Dialogues: Youths Forge Global Ties in 2026

Updated Category News Views 4

Bringing Global Youth to the Table In the heart of Jiangxi, China, young minds from across the globe gathered not just to chat but to shape the future. A bunch who only a decade ago might have been ignored in such circles are now leading discussions, and they’ve kicked off their powwow on September 22, 2026, with a bang in Nanchang. What’s the Agenda? Imagine more...

Continue Reading
AI in Music: CITY JAM Focuses on Human Creativity

Updated Category News Views 5

Breaking Down the AI Music Race In the wild world of music production, AI's making waves. Here's the thing though—it's all about how fast and how much it can churn out. Now, won't lie to you, that's impressive, but not the full picture. Pat Villaceran, the brain behind CITY JAM, is adamant that the real gold isn't just speed. It's the unique sound each artist brings to...

Continue Reading
KAPSARC Drives Energy Dialogue at WPC in Riyadh

Updated Category News Views 3

Defining Energy Horizons in Riyadh Mark those calendars, because as the global energy crowd descends on Riyadh from October 11 to 15, 2026, KAPSARC steps into the spotlight. As the National Partner at the 25th World Petroleum Congress (WPC), they're not just warming the bench—they're playing every position, shaking up the field of energy. Paving the Pathways with...

Continue Reading
New Docs Spotlight Psychiatry on World Mental Health Day

Updated Category News Views 3

Unmasking Mental Health on the Global Stage Hold onto your hats, folks. The Scientology Network is cranking up the heat this World Mental Health Day. On October 10, they’re rolling out a program that puts the spotlight on CCHR’s crusade against what they see as dark forces in the psychiatric industry. It’s a marathon of documentaries that dives into allegations of...

Continue Reading
NOARK: Powering Data Centers with Global-Local Approach

Updated Category News Views 4

The High-Stakes Race for Data Center Power These days, if you're not talking about data centers, you're probably a step behind the curve. AI's explosive growth is pushing data center developments across North America like never before. Larger campuses, hefty power densities—it's all happening at a pace that's got everyone scrambling. For folks like NOARK Electric, this...

Continue Reading
Kailas Campaign Binds Climbers with Gear, Trust

Updated Category News Views 4

Embracing the Spirit of Climbing Connections Alright, so when's the last time you saw a brand digging into the human side of one rugged sport like climbing? That's where Kailas steps in, pulling us beyond gear talk into the trust and camaraderie that defines climbing. Their latest effort—dubbed “Stay Warm, Stay Together”—goes beyond mere technical prowess by...

Continue Reading

Top 5 Most Recently Viewed Articles

Nominees for Tryg A/S Supervisory Board from TryghedsGruppen

Updated Category News Views 267

Nomination Overview for Tryg A/S Supervisory Board As preparations are underway for the annual general meeting, TryghedsGruppen smba has put forth an exciting slate of candidates for election to the Supervisory Board of Tryg A/S. This meeting, a key event for shareholders, is scheduled for the end of March. Meet the Candidates The candidates nominated by TryghedsGruppen...

Continue Reading
Laura Celeste Updegraff: Trailblazer in Military Leadership and HR

Updated Category News Views 194

Celebrating Leadership and Achievement Laura Celeste Updegraff, MBA, MS, stands out as a magnificent figure in leadership, recognized within The Inner Circle as a Pinnacle Professional Member Inner Circle of Excellence. Her remarkable journey highlights a deep commitment to service in the U.S. Army and a strong dedication to human resources leadership. A Distinguished...

Continue Reading
Corero Teams Up with Commercis for Regional Impact

Updated Category News Views 8

Diving into a Strategic Cybersecurity Partnership It's time to cut the chatter and zero in on a development straight from the cybersecurity trenches. Corero Network Security, trading under the catchy tickers CNS and DDOSF, is ramping things up in the Middle East through a fresh alliance with Commercis. Sitting on the edge, you might wonder, do we really need more...

Continue Reading
Niner Wine Estates Partners with Winebow for Distribution

Updated Category News Views 308

Niner Wine Estates Partners with Winebow Niner Wine Estates, a renowned family-owned winery known for its premium wines, has made a significant announcement regarding its distribution strategy. The winery has chosen Winebow Fine Wine & Spirits as its distribution partner in California. This partnership aims to elevate their presence in the competitive market and bring...

Continue Reading
Starbucks Boosts Dividend Amid Growth Challenges and Changes

Updated Category News Views 121

Starbucks Announces Increased Dividend Amid Growth Prospects Starbucks Corporation (NASDAQ: SBUX) has made headlines with its recent announcement of a raised quarterly cash dividend. The increase to $0.61 per share marks a significant moment, being the company's fourteenth consecutive annual hike. This raises the annual dividend rate to $2.44 per share, demonstrating the...

Continue Reading